Intravenous lidocaine infusion in a case of severe COVID-19 infection

A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local anesthetic lidocaine has anti-inflammatory propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Rylova, Anna, Chowdhury, Seema, Amirfarzan, Houman, Leissner, Kay B., Schumann, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562453/
https://www.ncbi.nlm.nih.gov/pubmed/34759566
http://dx.doi.org/10.4103/joacp.JOACP_562_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562453/
https://www.ncbi.nlm.nih.gov/pubmed/34759566
http://dx.doi.org/10.4103/joacp.JOACP_562_20

Ejemplares similares